AI Insight
This Nature article discusses a historical patent from the 1970s that significantly influenced the development of commercial biotechnology, specifically relating to recombinant DNA technology. The piece also mentions experimental work involving an anesthetic compound derived from puffball fungi. This appears to be part of Nature's regular feature examining notable items from their publication archives.
Why it matters
The 1970s patent for recombinant DNA technology laid the legal and commercial foundation for the modern biotechnology industry, enabling the development of genetically engineered products including therapeutic proteins, vaccines, and other biologics. This historical context helps understand how intellectual property frameworks shaped the trajectory of an entire scientific field.
Understand the Science
Nature, Published online: 23 June 2026; doi:10.1038/d41586-026-01812-1
The scientific community awaits a patent for recombinant DNA technology, and experimentation with an anaesthetic from puffballs, in our weekly dip into Nature’s archive.
Source: A 1970s patent that changed the course of commercial biotechnology